However, despite the positive effect of VEGF blockade on the leakiness of vessels and regression of neovascularization, severe damage like geographic atrophy and poor vision has been observed in AMD patients after extended treatment with anti-VEGF antibodies [23–25]. Here, VEGFA is linked to age-related macular degeneration.